Literature DB >> 16188892

Human topoisomerase IIalpha rapidly relaxes positively supercoiled DNA: implications for enzyme action ahead of replication forks.

A Kathleen McClendon1, A Chapin Rodriguez, Neil Osheroff.   

Abstract

Movement of the DNA replication machinery through the double helix induces acute positive supercoiling ahead of the fork and precatenanes behind it. Because topoisomerase I and II create transient single- and double-stranded DNA breaks, respectively, it has been assumed that type I enzymes relax the positive supercoils that precede the replication fork. Conversely, type II enzymes primarily resolve the precatenanes and untangle catenated daughter chromosomes. However, studies on yeast and bacteria suggest that type II topoisomerases may also function ahead of the replication machinery. If this is the case, then positive DNA supercoils should be the preferred relaxation substrate for topoisomerase IIalpha, the enzyme isoform involved in replicative processes in humans. Results indicate that human topoisomerase IIalpha relaxes positively supercoiled plasmids >10-fold faster than negatively supercoiled molecules. In contrast, topoisomerase IIbeta, which is not required for DNA replication, displays no such preference. In addition to its high rates of relaxation, topoisomerase IIalpha maintains lower levels of DNA cleavage complexes with positively supercoiled molecules. These properties suggest that human topoisomerase IIalpha has the potential to alleviate torsional stress ahead of replication forks in an efficient and safe manner.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16188892     DOI: 10.1074/jbc.M503320200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  82 in total

Review 1.  DNA topoisomerases and their poisoning by anticancer and antibacterial drugs.

Authors:  Yves Pommier; Elisabetta Leo; HongLiang Zhang; Christophe Marchand
Journal:  Chem Biol       Date:  2010-05-28

2.  Relationship of DNA damage signaling to DNA replication following treatment with DNA topoisomerase inhibitors camptothecin/topotecan, mitoxantrone, or etoposide.

Authors:  Hong Zhao; Paulina Rybak; Jurek Dobrucki; Frank Traganos; Zbigniew Darzynkiewicz
Journal:  Cytometry A       Date:  2011-12-02       Impact factor: 4.355

3.  Evolutionary twist on topoisomerases: conversion of gyrase to topoisomerase IV.

Authors:  Keir C Neuman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-17       Impact factor: 11.205

4.  Single-Molecule Supercoil Relaxation Assay as a Screening Tool to Determine the Mechanism and Efficacy of Human Topoisomerase IB Inhibitors.

Authors:  Yeonee Seol; Hongliang Zhang; Keli Agama; Nicholas Lorence; Yves Pommier; Keir C Neuman
Journal:  Mol Cancer Ther       Date:  2015-09-08       Impact factor: 6.261

5.  The geometry of DNA supercoils modulates topoisomerase-mediated DNA cleavage and enzyme response to anticancer drugs.

Authors:  A Kathleen McClendon; Neil Osheroff
Journal:  Biochemistry       Date:  2006-03-07       Impact factor: 3.162

Review 6.  DNA topoisomerase II and its growing repertoire of biological functions.

Authors:  John L Nitiss
Journal:  Nat Rev Cancer       Date:  2009-04-20       Impact factor: 60.716

7.  Mechanisms of chiral discrimination by topoisomerase IV.

Authors:  K C Neuman; G Charvin; D Bensimon; V Croquette
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-09       Impact factor: 11.205

8.  Characterization of the nucleoid-associated protein YejK.

Authors:  Chong Lee; Kenneth J Marians
Journal:  J Biol Chem       Date:  2013-09-16       Impact factor: 5.157

Review 9.  Topoisomerases and the regulation of neural function.

Authors:  Peter J McKinnon
Journal:  Nat Rev Neurosci       Date:  2016-09-15       Impact factor: 34.870

10.  The Dynamic Interplay Between DNA Topoisomerases and DNA Topology.

Authors:  Yeonee Seol; Keir C Neuman
Journal:  Biophys Rev       Date:  2016-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.